Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects

AIM: To evaluate the safety, tolerability and pharmacokinetics (PK) of udenafil, a novel phosphodiesterase type 5 inhibitor. METHODS: A double-blind, randomized, placebo-controlled, dose-rising, parallel-group, single- and multiple-dose study was conducted in healthy Korean subjects. The subjects we...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kim, Bo-Hyung, Lim, Hyeong-Seok, Chung, Jae-Yong, Kim, Jung-Ryul, Lim, Kyoung Soo, Sohn, Dong-Ryul, Cho, Joo-Youn, Yu, Kyung-Sang, Shin, Sang-Goo, Paick, Jae-Seung, Jang, In-Jin
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Science Inc 2008
Matèries:
Pharmacodynamics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2485225/
https://ncbi.nlm.nih.gov/pubmed/18318773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2008.03107.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars